Private Equity

PE Fund Investments

Kotak Fund to invest $200-M to back Iquest's acqn of Viatris API biz: report

Economic Times  

Kotak Strategic Situations Fund (KSSF) is to invest about INR 1,600 crore (USD 200 million), via a combination of structured debt and equity, in the active pharmaceutical ingredients (API) business that Nimmagadda Prasad-promoted Iquest Enterprises acquired from Viatris last week for USD 450 million (INR 3,800 crore). Besides Kotak, Deutsche Bank and DBS have also financed the acquisition. Prasad, founder of Matrix Laboratories, had sold his API manufacturing business to Mylan (rebranded as Viatris) in 2007.